BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
171 results:

  • 1. Genetic Polymorphisms of XPC, xpd, XPG Genes and their Association with Radiotherapy Induced Toxicity among head and neck cancer Patients: A Hospital Based Study from Maharashtra.
    Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic head and neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08).
    Wang HM; Lou PJ; Yang MH; Chen TH; Lien MY; Lin JC; Chen JP; Lu WC; Lu HJ; Huang TL; Yen CJ; Wu SY; Wang HC; Hsieh MC
    Target Oncol; 2024 Jan; 19(1):51-58. PubMed ID: 38285067
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
    Alfieri S; Romanò R; Marceglia S; De Giorgi V; Peris K; Sollena P; Piccerillo A; Moro R; Gualdi G; Ascierto PA; Palla M; Paone M; Eibenschutz L; Spagnolo F; Queirolo P; Filippini DM; Cavalieri S; Resteghini C; Bergamini C; Manocchio A; Licitra L; Bossi P
    Oncologist; 2024 May; 29(5):e699-e707. PubMed ID: 38127280
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
    Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
    Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical presentation of childhood soft tissue sarcomas: a systematic review and meta-analysis.
    Ni Cheallaigh L; Liu JF; Fern L; Winyard P; Walker D; Ball-Gamble A; Shanmugavadivel D
    Arch Dis Child; 2024 Jan; 109(2):113-120. PubMed ID: 37857451
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
    Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
    Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.
    Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP
    Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association between the Preoperative Dietary Antioxidant Index and Postoperative Quality of Life in Patients with Esophageal Squamous Cell Carcinoma: A Prospective Study Based on the ttd Model.
    Zhang J; Zhou J; Huang Y; Lin Z; Zhang S; Qiu M; Xiang Z; Hu Z
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447155
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Extra-mandibular Osteoradionecrosis after the Treatment of head and neck cancer.
    Kovarik PDE; Patil R; Cvek J; Kelly C; Jackson M; Mackenzie L; West N; Willis N; Kovarik JP; Banks R; Kennedy M; Adams J; Iqbal MS
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e498-e505. PubMed ID: 37433701
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.
    Zhu F; Li F; Xie X; Wu Y; Wang W
    Cancer Med; 2023 Jun; 12(12):13290-13299. PubMed ID: 37132252
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study.
    Zhang J; Lin Z; Zhou J; Huang Y; Chen S; Deng Y; Qiu M; Chen Y; Hu Z
    BMC Cancer; 2023 Apr; 23(1):342. PubMed ID: 37055773
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
    Elbasan O; Ilgın C; Gogas Yavuz D
    Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Improvement of postoperative quality of life in patients with esophageal squamous cell carcinoma: does tea consumption have a role?
    Zhang J; Liu S; Song J; Zhou J; Zeng Q; Lin Z; Yu K; Zhang S; Qiu M; Chen Y; Hu Z
    BMC Public Health; 2022 Nov; 22(1):2165. PubMed ID: 36424573
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Characterization of genetic polymorphisms in oral cancer-related genes pertaining to oxidative stress, carcinogen detoxifying, and DNA repair: A case-control study.
    Tata NH; Kshirsagar A; Nangare N
    J Cancer Res Ther; 2022; 18(4):1023-1029. PubMed ID: 36149156
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of head and neck Squamous Cell Carcinomas in a Chinese Population.
    Liang Y; Zhang L; Chen Z; Chen J; Fang S; Zhang T; Zhu Y; Liu J; Li B; Shao Y; Xing J; Zhang S; Han P
    Dis Markers; 2022; 2022():4959737. PubMed ID: 36118674
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
    Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
    J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
    Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
    Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
    Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SEOM-GEMCAD-ttd Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021).
    Fernández-Montes A; Alcaide J; Alsina M; Custodio AB; Franco LF; Gallego Plazas J; Gómez-Martín C; Richart P; Rivera F; Martin-Richard M
    Clin Transl Oncol; 2022 Apr; 24(4):658-669. PubMed ID: 35347573
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
    Löck S; Linge A; Lohaus F; Ebert N; Gudziol V; Nowak A; Tinhofer I; Kalinauskaite G; Guberina M; Stuschke M; Balermpas P; von der Grün J; Grosu AL; Debus J; Ganswindt U; Belka C; Peeken JC; Combs SE; De-Colle C; Zips D; Baretton GB; Krause M; Baumann M;
    Radiother Oncol; 2022 Apr; 169():8-14. PubMed ID: 35182686
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.